Case Report
Anti-PD1 Treatment of Progressive Multifocal Leucencephalopathy in a Patient with Multiple Myeloma Treated with Anti-Bcma Bispecific Antibodies: A Case Report
Relapsed/refractory multiple myeloma (RRMM) is still an incurable disease with poor prognosis. Bispecific antibodies, such as Teclistamab, are a new promising option for these pati...